Nuveen’s Boston Scientific BSX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $371M | Sell |
8,695,119
-3,039,195
| -26% | -$165M | 0.09% | 174 |
|
|
2026
Q1 | $736M | Buy |
11,734,314
+2,362,020
| +25% | +$189M | 0.2% | 96 |
|
|
2025
Q4 | $894M | Sell |
9,372,294
-273,944
| -3% | -$26.9M | 0.23% | 79 |
|
|
2025
Q3 | $942M | Buy |
9,646,238
+189,878
| +2% | +$19.7M | 0.25% | 75 |
|
|
2025
Q2 | $1.02B | Buy |
9,456,360
+2,461,003
| +35% | +$249M | 0.28% | 66 |
|
|
2025
Q1 | $679M | Sell |
6,995,357
-2,933,923
| -30% | -$295M | 0.21% | 89 |
|
|
2024
Q4 | $887M | Sell |
9,929,280
-1,404,182
| -12% | -$124M | 0.25% | 69 |
|
|
2024
Q3 | $950M | Buy |
11,333,462
+22,796
| +0.2% | +$1.8M | 0.27% | 68 |
|
|
2024
Q2 | $871M | Sell |
11,310,666
-646,148
| -5% | -$47.3M | 0.25% | 71 |
|
|
2024
Q1 | $819M | Buy |
11,956,814
+1,607,586
| +16% | +$103M | 0.24% | 81 |
|
|
2023
Q4 | $598M | Buy |
10,349,228
+786,774
| +8% | +$42M | 0.19% | 103 |
|
|
2023
Q3 | $505M | Buy |
9,562,454
+208,515
| +2% | +$10.9M | 0.18% | 116 |
|
|
2023
Q2 | $506M | Buy |
9,353,939
+1,323,650
| +16% | +$69.1M | 0.18% | 114 |
|
|
2023
Q1 | $402M | Sell |
8,030,289
-1,163,413
| -13% | -$54.8M | 0.15% | 133 |
|
|
2022
Q4 | $425M | Sell |
9,193,702
-1,359,226
| -13% | -$58.9M | 0.16% | 128 |
|
|
2022
Q3 | $409M | Buy |
10,552,928
+1,036,331
| +11% | +$41.6M | 0.17% | 122 |
|
|
2022
Q2 | $355M | Buy |
9,516,597
+125,891
| +1% | +$5.12M | 0.14% | 141 |
|
|
2022
Q1 | $416M | Buy |
9,390,706
+2,021,204
| +27% | +$87.6M | 0.13% | 147 |
|
|
2021
Q4 | $313M | Sell |
7,369,502
-1,107,831
| -13% | -$46.6M | 0.09% | 205 |
|
|
2021
Q3 | $368M | Sell |
8,477,333
-2,009,244
| -19% | -$88.9M | 0.11% | 163 |
|
|
2021
Q2 | $448M | Sell |
10,486,577
-3,580,303
| -25% | -$151M | 0.13% | 145 |
|
|
2021
Q1 | $544M | Sell |
14,066,880
-497,649
| -3% | -$18.8M | 0.17% | 119 |
|
|
2020
Q4 | $524M | Sell |
14,564,529
-8,270,168
| -36% | -$298M | 0.18% | 117 |
|
|
2020
Q3 | $873M | Buy |
22,834,697
+1,559,242
| +7% | +$60.1M | 0.34% | 64 |
|
|
2020
Q2 | $747M | Buy |
21,275,455
+733,415
| +4% | +$26.4M | 0.3% | 69 |
|
|
2020
Q1 | $670M | Buy |
20,542,040
+7,914,016
| +63% | +$309M | 0.33% | 68 |
|
|
2019
Q4 | $571M | Buy |
12,628,024
+1,693,953
| +15% | +$70.9M | 0.22% | 98 |
|
|
2019
Q3 | $445M | Buy |
10,934,071
+2,136,455
| +24% | +$90.5M | 0.18% | 116 |
|
|
2019
Q2 | $378M | Buy |
8,797,616
+8,645,002
| +5,665% | +$333M | 0.15% | 137 |
|
|
2019
Q1 | $5.86M | Sell |
152,614
-3,704
| -2% | -$141K | 0.03% | 481 |
|
|
2018
Q4 | $5.52M | Sell |
156,318
-1,058
| -0.7% | -$38.4K | 0.03% | 472 |
|
|
2018
Q3 | $6.06M | Buy |
157,376
+205
| +0.1% | +$7.16K | 0.03% | 493 |
|
|
2018
Q2 | $5.14M | Buy |
157,171
+68,994
| +78% | +$2.08M | 0.03% | 480 |
|
|
2018
Q1 | $2.41M | Sell |
88,177
-8,867
| -9% | -$241K | 0.02% | 592 |
|
|
2017
Q4 | $2.41M | Sell |
97,044
-163,126
| -63% | -$4.5M | 0.02% | 573 |
|
|
2017
Q3 | $7.59M | Sell |
260,170
-79,479
| -23% | -$2.19M | 0.05% | 437 |
|
|
2017
Q2 | $9.41M | Sell |
339,649
-81,060
| -19% | -$2.15M | 0.06% | 421 |
|
|
2017
Q1 | $10.5M | Sell |
420,709
-114,258
| -21% | -$2.78M | 0.06% | 416 |
|
|
2016
Q4 | $11.6M | Sell |
534,967
-4,145
| -0.8% | -$90.4K | 0.06% | 413 |
|
|
2016
Q3 | $12.8M | Sell |
539,112
-505,933
| -48% | -$12.1M | 0.07% | 319 |
|
|
2016
Q2 | $24.4M | Sell |
1,045,045
-356,702
| -25% | -$7.72M | 0.15% | 171 |
|
|
2016
Q1 | $26.4K | Sell |
1,401,747
-257,040
| -15% | -$4.52M | 0.14% | 155 |
|
|
2015
Q4 | $30.6K | Sell |
1,658,787
-18,213
| -1% | -$326K | 0.16% | 139 |
|
|
2015
Q3 | $27.5K | Sell |
1,677,000
-271,556
| -14% | -$4.64M | 0.16% | 154 |
|
|
2015
Q2 | $34.5K | Sell |
1,948,556
-118,204
| -6% | -$2.11M | 0.18% | 128 |
|
|
2015
Q1 | $36.7M | Buy |
2,066,760
+1,597,543
| +340% | +$25.2M | 0.2% | 129 |
|
|
2014
Q4 | $6.22M | Buy |
469,217
+344,476
| +276% | +$4.4M | 0.03% | 496 |
|
|
2014
Q3 | $1.47M | Sell |
124,741
-984
| -0.8% | -$12.4K | 0.01% | 956 |
|
|
2014
Q2 | $1.61M | Sell |
125,725
-271,032
| -68% | -$3.52M | 0.01% | 915 |
|
|
2014
Q1 | $5.36M | Sell |
396,757
-16,434
| -4% | -$216K | 0.03% | 515 |
|
|
2013
Q4 | $4.97M | Buy |
413,191
+222,313
| +116% | +$2.63M | 0.03% | 513 |
|
|
2013
Q3 | $2.24M | Buy |
190,878
+78,646
| +70% | +$851K | 0.01% | 755 |
|
|
2013
Q2 | $1.04M | Buy |
+112,232
| New | +$952K | 0.01% | 1011 |
|
Other funds holding BSX
Nuveen's BSX Position: Q2 2026 in Review
Nuveen reduced its Boston Scientific (BSX) stake by 26% in Q2 2026, selling an estimated $165M and leaving 8,695,119 shares worth $371M. The position accounts for 0.09% of the portfolio, ranked #174.
Nuveen first reported a position in BSX in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.02B in Q2 2025. 1,468 funds tracked by Wall St. Rank hold BSX as of Q2 2026.
- Nuveen held 8,695,119 shares of Boston Scientific worth $371M as of Q2 2026.
- Nuveen sold 3,039,195 Boston Scientific shares in Q2 2026, an estimated $165M.
- Boston Scientific made up 0.09% of Nuveen's portfolio in Q2 2026, its #174 holding.
- Nuveen first reported a position in Boston Scientific in Q2 2013 and has held it in 53 quarters since.
- Nuveen's Boston Scientific position peaked at $1.02B in Q2 2025.
- 1,468 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.
Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.